60 Degrees Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net income was USD 0.43047 million compared to net loss of USD 2.6 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to basic loss per share from continuing operations of USD 1.13 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2529 USD | -5.85% |
|
-10.32% | -75.21% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-75.21% | 3.09M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- SXTP Stock
- News 60 Degrees Pharmaceuticals, Inc.
- 60 Degrees Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024